These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18269306)
1. Cost-effectiveness of telephonic disease management in heart failure. Smith B; Hughes-Cromwick PF; Forkner E; Galbreath AD Am J Manag Care; 2008 Feb; 14(2):106-15. PubMed ID: 18269306 [TBL] [Abstract][Full Text] [Related]
2. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Galbreath AD; Krasuski RA; Smith B; Stajduhar KC; Kwan MD; Ellis R; Freeman GL Circulation; 2004 Dec; 110(23):3518-26. PubMed ID: 15531765 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Calvert MJ; Freemantle N; Yao G; Cleland JG; Billingham L; Daubert JC; Bryan S; Eur Heart J; 2005 Dec; 26(24):2681-8. PubMed ID: 16284203 [TBL] [Abstract][Full Text] [Related]
4. Long-term cost-effectiveness of disease management in systolic heart failure. Miller G; Randolph S; Forkner E; Smith B; Galbreath AD Med Decis Making; 2009; 29(3):325-33. PubMed ID: 19147835 [TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of telephone case management in Hispanics of Mexican origin with heart failure. Riegel B; Carlson B; Glaser D; Romero T J Card Fail; 2006 Apr; 12(3):211-9. PubMed ID: 16624687 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care. Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843 [TBL] [Abstract][Full Text] [Related]
7. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial. Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325 [TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Kimmelstiel C; Levine D; Perry K; Patel AR; Sadaniantz A; Gorham N; Cunnie M; Duggan L; Cotter L; Shea-Albright P; Poppas A; LaBresh K; Forman D; Brill D; Rand W; Gregory D; Udelson JE; Lorell B; Konstam V; Furlong K; Konstam MA Circulation; 2004 Sep; 110(11):1450-5. PubMed ID: 15313938 [TBL] [Abstract][Full Text] [Related]
10. [Impact of a nurse-based heart failure management program on hospitalization rate, functional status, quality of life, and medical costs]. Chinaglia A; Gaschino G; Asteggiano R; Titta G; Gullstrand R; Bobbio M; Trinchero R Ital Heart J Suppl; 2002 May; 3(5):532-8. PubMed ID: 12064192 [TBL] [Abstract][Full Text] [Related]
11. A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure. Postmus D; Pari AA; Jaarsma T; Luttik ML; van Veldhuisen DJ; Hillege HL; Buskens E Am Heart J; 2011 Dec; 162(6):1096-104. PubMed ID: 22137084 [TBL] [Abstract][Full Text] [Related]
12. Heart failure disease management in an indigent population. O'Connell AM; Crawford MH; Abrams J Am Heart J; 2001 Feb; 141(2):254-8. PubMed ID: 11174340 [TBL] [Abstract][Full Text] [Related]
13. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Smith B; Forkner E; Zaslow B; Krasuski RA; Stajduhar K; Kwan M; Ellis R; Galbreath AD; Freeman GL Am J Manag Care; 2005 Nov; 11(11):701-13. PubMed ID: 16268753 [TBL] [Abstract][Full Text] [Related]
14. Which patients with heart failure respond best to multidisciplinary disease management? Riegel B; Carlson B; Glaser D; Hoagland P J Card Fail; 2000 Dec; 6(4):290-9. PubMed ID: 11145753 [TBL] [Abstract][Full Text] [Related]
15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Sorensen SV; Frick KD; Wade A; Simko R; Burge R Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159 [TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of cardiac resynchronization therapy: perspective from Argentina. Poggio R; Augustovsky F; Caporale J; Irazola V; Miriuka S Int J Technol Assess Health Care; 2012 Oct; 28(4):429-35. PubMed ID: 23006489 [TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results. Bocchi EA; da Cruz FDD; BrandÃo SM; Issa V; Ayub-Ferreira SM; Brunner la Rocca HP; Wijk SS J Card Fail; 2018 Oct; 24(10):627-637. PubMed ID: 29723595 [TBL] [Abstract][Full Text] [Related]
20. Cost-effective care a phone call away: a nurse-managed telephonic program for patients with chronic heart failure. Slater MR; Phillips DM; Woodard EK Nurs Econ; 2008; 26(1):41-4. PubMed ID: 18389841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]